+454.2%
MRNA vs VT
+20.4%
+433.8%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | VT | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -0.6% | -2.7% | -2.0% |
| 7D | -10.1% | -0.1% | -9.9% | -9.8% |
| 30D | +126.7% | -0.7% | +127.4% | +131.5% |
| 3M | +184.1% | +4.0% | +180.1% | +168.0% |
| 6M | +143.3% | +12.3% | +131.0% | +101.8% |
| YTD | +359.9% | +14.0% | +345.8% | +269.1% |
| 1Y | +454.2% | +20.3% | +433.9% | +270.5% |
| All | +454.2% | +20.4% | +433.8% | +270.5% |
Cumulative growth
Daily Returns
Daily percentage return beside VT.
Daily Out/Under-Performance
Portfolio return minus VT return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded VT wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling